Skip to content
Open access

Development and Validation of an LC–MS/MS Method for the Quantitative Determination of Vildagliptin in Analytical Standard Solutions Using Linagliptin as an Internal Standard

Aug 2026 · Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi · Vol 19, pp. 182-193 · 0 citations · 12 references

TL;DR

An LC–MS/MS procedure was developed and evaluated for measuring vildagliptin in analytical standard solutions, with linagliptin serving as the internal standard and the validation applies to prepared analytical solutions and does not establish performance in dosage forms or biological matrices.

Abstract

An LC–MS/MS procedure was developed and evaluated for measuring vildagliptin in analytical standard solutions, with linagliptin serving as the internal standard. Reference materials dissolved in acetonitrile were used to produce the calibration and quality-control (QC) solutions, and six independently prepared placebo samples were examined for excipient-related interference. An ACE C18 column (50 mm × 2.1 mm, 5 µm) was operated under gradient conditions at 0.3 mL min⁻¹ with 10 mM ammonium acetate and acetonitrile as the aqueous and organic components; each contained 0.01% formic acid. Positive-ion electrospray and multiple-reaction monitoring were used for detection. Across the validated interval of 0.125–4.0 ng mL⁻¹, the calibration model gave R² = 0.9951. Instrumental LOD and LOQ values in the injected solutions were 0.028 and 0.084 ng mL⁻¹, respectively. The highest intra-day or inter-day precision value was 2.15% RSD. At the three QC levels, mean recovery was 99.12–101.7%, and recovery RSD was 2.00–3.29% (n = 6). Each chromatographic cycle lasted 7.5 min. No interfering vildagliptin MRM peak was detected in the placebo preparations, although ion suppression and enhancement were not measured quantitatively. The validation applies to prepared analytical solutions and does not establish performance in dosage forms or biological matrices.

Read PDF

Similar papers

Open access 2025

DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING UPLC–PDA METHOD FOR SIMULTANEOUS DETERMINATION OF MIRDAMETINIB AND ITS SPECIFIED IMPURITIES

A rapid, sensitive, and reliable reversed-phase UPLC–PDA method was developed and validated for the simultaneous determination of Mirdametinib and its three process-related impurities (Mirdametinib Impurity-1, Impurity-2, and Impurity-3) in pharmaceutical formulations. Chromatographic separation was achieved using a BE...

P. Pranaya, K. Gandla · 0 citations
Open access Oct 2026

Development and validation of a practical LC–MS/MS method for the quantification of finasteride in rat plasma using liquid–liquid extraction from 50 μL plasma samples

Reliable quantification of finasteride (FNS) in small-volume plasma samples is essential for preclinical pharmacokinetic studies but requires analytical methods that combine adequate sensitivity with practical sample preparation. In this study, a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method coupled...

Yuna Ha, Seung-Min Lee, Han Hoe Lee et al. · 0 citations
Oct 2026

A sensitive assay for estimation of DM1 fortified with trastuzumab in human serum utilizing positive LC-MS/MS electrospray ionization and its application to clinical study.

AIM A sensitive LC-MS/MS method was developed and validated for the estimation of DM1 fortified with trastuzumab in human serum. MATERIALS AND METHODS Quantification was performed in positive mode with protein precipitation extraction using DM4 as an internal standard. Chromatographic separation was achieved using gr...

A. Ghoghari, Harilal V. Patel, Chandrakant Bhatt et al. · 0 citations
Open access Oct 2026

Development and Validation of an UPLC-QqQ MS/MS Method for the Determination of Daraxonrasib, a New pan-KRAS Inhibitor, in Dog Plasma and Whole Blood and Its Application to Pharmacokinetic Studies.

Daraxonrasib, an orally administered pan-RAS inhibitor, is undergoing clinical evaluation for pancreatic ductal adenocarcinoma, colorectal cancer, and non-small cell lung cancer. Defining its pharmacokinetic profile is therefore critical for ongoing progress. Accordingly, a simple and sensitive UPLC-QqQ-MS/MS assay was...

Wen-Tao Zhang, Yan-Zi Liu, Ali Fan et al. · 0 citations
Open access Oct 2026

Development and Validation of Liquid Chromatography–Tandem Mass Spectrometry Method for Quantification of Lazertinib in Plasma Samples and Pharmacokinetic Study in Rabbits

The aim of the present study was to establish a precise, linear, and specific liquid chromatography‐electrospray ionization‐tandem mass spectrometry (LC–ESI–MS/MS) technique for the quantitative estimation of lazertinib in plasma of rabbits. Analyte separation was accomplished on a Phenomenex C18 (50 × 4.6 mm, 2.1...

Balakrishna Attuluri, M. Rudrapal, Venkateswararao B et al. · 0 citations
Open access Oct 2026

Systematic Development and Validation of Analytical Techniques for Simultaneous Quantification of Ertugliflozin and Metformin Hydrochloride in Bulk and Pharmaceutical Formulations

: To evaluate Simultaneous Quantification of Ertugliflozin and Metformin Hydrochloride in Bulk and Pharmaceutical Formulations, a quick, reliable and consistent method was developed. The drugs were injected in to the inertsil C18 (250 x 4.6 mm) maintained at room temp and wavelength 220 nm. The mobile phase consists of...

S. Khan, Saleem Khan, Imran Khan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.